Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Merritt

Showing results (401-410 of 510) with videos related to

Pageof 51
Sort By:
Antimicrobial Agents and Chemotherapy|March 21, 2018
Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift AssaysSuzanne Scheele, Jennifer A Geiger, Amy E DeRocher, et al.
Journal of Molecular Biology|March 23, 2011
The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimerEric T Larson, Jessica E Kim, Lisa J Castaneda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinomaG L Clayman, A K el-Naggar, S M Lippman, et al.
Plos One|December 5, 2013
Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomesMelissa A Merritt, Stefan Bentink, Matthew Schwede, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Structure of the conserved hypothetical protein MAL13P1.257 from Plasmodium falciparumMargaret A Holmes, Frederick S Buckner, Wesley C Van Voorhis, et al.
Molecular Microbiology|March 4, 2008
Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studiesTracy L Arakaki, Frederick S Buckner, J Robert Gillespie, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
Journal of Molecular Biology|July 8, 2008
Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivityEric T Larson, Wei Deng, Brian E Krumm, et al.
Plos One|April 1, 2014
Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapyKayode K Ojo, Molly C Reid, Latha Kallur Siddaramaiah, et al.
Molecular Cell|April 9, 2019
A Combined Approach Reveals a Regulatory Mechanism Coupling Src's Kinase Activity, Localization, and Phosphotransferase-Independent FunctionsEthan Ahler, Ames C Register, Sujata Chakraborty, et al.
Pageof 51

Showing results (401-410 of 510) with videos related to

Sort By:
Pageof 51
Antimicrobial Agents and Chemotherapy|March 21, 2018
Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift AssaysSuzanne Scheele, Jennifer A Geiger, Amy E DeRocher, et al.
Journal of Molecular Biology|March 23, 2011
The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimerEric T Larson, Jessica E Kim, Lisa J Castaneda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinomaG L Clayman, A K el-Naggar, S M Lippman, et al.
Plos One|December 5, 2013
Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomesMelissa A Merritt, Stefan Bentink, Matthew Schwede, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Structure of the conserved hypothetical protein MAL13P1.257 from Plasmodium falciparumMargaret A Holmes, Frederick S Buckner, Wesley C Van Voorhis, et al.
Molecular Microbiology|March 4, 2008
Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studiesTracy L Arakaki, Frederick S Buckner, J Robert Gillespie, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
Journal of Molecular Biology|July 8, 2008
Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivityEric T Larson, Wei Deng, Brian E Krumm, et al.
Plos One|April 1, 2014
Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapyKayode K Ojo, Molly C Reid, Latha Kallur Siddaramaiah, et al.
Molecular Cell|April 9, 2019
A Combined Approach Reveals a Regulatory Mechanism Coupling Src's Kinase Activity, Localization, and Phosphotransferase-Independent FunctionsEthan Ahler, Ames C Register, Sujata Chakraborty, et al.
Pageof 51